Cerebain Biotech Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2019
May 20, 2019 at 11:58 pm IST
Cerebain Biotech Corp. announced earnings results for the third quarter ended March 31, 2019. For the third quarter, the company announced net loss was USD 390,209 compared to USD 654,602 a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.07 a year ago. For the nine months, net loss was USD 1.298 million compared to USD 4.499 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.54 a year ago.